Area of research
Oncology · Genetics
Research interest
Research focused on Cancer research and Collinearity, with related work in Epigenetics, Demography, Clear cell renal cell carcinoma. Notable publications include 'A Study of Effects of MultiCollinearity in the Multivariable Analysis', 'Time Course of LDL Cholesterol Exposure and Cardiovascular Disease Event Risk', and 'The presence of a cytopathologist increases the diagnostic accuracy of endoscopic ultrasound‐guided fine needle aspiration cytology for pancreatic adenocarcinoma: a meta‐analysis'.
ADT-1004: a first-in-class, oral pan-RAS inhibitor with robust antitumor activity in preclinical models of pancreatic ductal adenocarcinoma
HER2 alterations across solid tumors: implications for comprehensive testing
YIA25-001: Molecular Residual Disease (MRD) Guided Adjuvant Therapy In Renal Cell Carcinoma (RCC) - The MRD GATE RCC Study
A Pan-RAS Inhibitor with a Unique Mechanism of Action Blocks Tumor Growth and Induces Antitumor Immunity in Gastrointestinal Cancer
l-2-Hydroxyglutarate remodeling of the epigenome and epitranscriptome creates a metabolic vulnerability in kidney cancer models
Fuzzy Bayesian network analysis for quantifying risk reduction rate of hierarchy of controls
CRISPR-based dissection of microRNA-23a ~ 27a ~ 24-2 cluster functionality in hepatocellular carcinoma
Predicting outcomes in head and neck surgery with modified frailty index and surgical apgar scores
ADT-1004: A First-in-Class, Orally Bioavailable Selective pan-RAS Inhibitor for Pancreatic Ductal Adenocarcinoma
Association of Incident Cardiovascular Disease With Time Course and Cumulative Exposure to Multiple Risk Factors
Microbiome diversity in African American, European American, and Egyptian colorectal cancer patients
A Novel Pan-RAS Inhibitor with a Unique Mechanism of Action Blocks Tumor Growth in Mouse Models of GI Cancer
Evaluation of RANO Criteria for the Assessment of Tumor Progression for Lower-Grade Gliomas
TUBB4A interacts with MYH9 to protect the nucleus during cell migration and promotes prostate cancer via GSK3β/β-catenin signalling
Dual CRISPR interference and activation for targeted reactivation of X-linked endogenous FOXP3 in human breast cancer cells
Epigenetic regulation of EIF4A1 through DNA methylation and an oncogenic role of eIF4A1 through BRD2 signaling in prostate cancer
Attitudes toward telemedicine among urban and rural residents
Safety and Efficacy of Intraventricular Immunovirotherapy with Oncolytic HSV-1 for CNS Cancers
Fibrinogen mediates cadmium-induced macrophage activation and serves as a predictor of cadmium exposure in chronic obstructive pulmonary disease
Differences in Breast and Colorectal Cancer Screening Adherence Among Women Residing in Urban and Rural Communities in the United States
Serine-threonine Kinase Receptor-Associated Protein is a Critical Mediator of APC Mutation–Induced Intestinal Tumorigenesis Through a Feed-Forward Mechanism
CRISPR interference and activation of the microRNA-3662-HBP1 axis control progression of triple-negative breast cancer
Knocking out the Vitamin D Receptor Enhances Malignancy and Decreases Responsiveness to Vitamin D3 Hydroxyderivatives in Human Melanoma Cells
Time Course of LDL Cholesterol Exposure and Cardiovascular Disease Event Risk
Biological and Clinical Significance of the CCR5/CCL5 Axis in Hepatocellular Carcinoma
14-3-3 proteins protect AMPK-phosphorylated ten-eleven translocation-2 (TET2) from PP2A-mediated dephosphorylation
Perioperative outcomes of laparoscopic, robotic, and open approaches to pheochromocytoma
Selective Targeting of the Hedgehog Signaling Pathway by PBM Nanoparticles in Docetaxel-Resistant Prostate Cancer
A CD24‐p53 axis contributes to African American prostate cancer disparities
Expression of trefoil factor 3 is decreased in colorectal cancer